Arno Trading Est. Pharmaceutical Import Profile — Jordan (DGFT 2022–2026)

Name: Arno Trading Est. Pharmaceutical Import Records from India — 2 Products, $67.1K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Arno Trading Est. — Pharmaceutical Importer Profile (2026) | 2 Products, $67.1K Trade | TransData Nexus

Who Are the Verified Indian Suppliers to Arno Trading Est.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Neon Laboratories Limited	$143.2K	9	56.3%
Panacea Biotec Pharma Limited	$111.2K	3	43.7%

Arno Trading Est. sources from 2 verified Indian suppliers across 9 distinct formulations. Total import value: $254.4K across 12 shipments.

What Formulations Does Arno Trading Est. Import?

Formulation	Value	Ships
Bemustin injection (bendamustine	$71.6K	2
Dacarbazine for injection USP (lyophilised) 100MG/vial-zicarb	$40.3K	2
Vagacyte (valganciclovir tablets USP	$39.5K	1
Anawin heavy bupivacaine hydrochloride	$36.8K	1
Thiosol thiopental sodium for	$36.0K	1
Zicarb 200 dacarbazine for injection	$10.0K	1
Zicarb 100 dacarbazine for injection	$9.0K	1

What Products Does Arno Trading Est. Import?

Top Products by Import Value

1Dacarbazine$59.3K 2Mitoxantrone$7.9K

Arno Trading Est. Therapeutic Categories — 1 Specializations

Arno Trading Est. imports across 1 therapeutic categories, with Advanced Oncology (100.0%), representing the largest segments. The portfolio is concentrated — top 5 products = 100% of total imports.

Advanced Oncology

2 products · 100.0% · $67.1K

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Dacarbazine	Advanced Oncology	$59.3K	4	2.8%	6
2	Mitoxantrone	Advanced Oncology	$7.9K	2	0.4%	7

Key Metrics

Total Import Value$67.1K

Products2

Shipments6

Categories1

CountryJordan

#1 Rankings0

Indian Suppliers2

Formulations9

Top Categories

Advanced Oncology100.0%

Indian Suppliers

Last updated: March 28, 2026

Arno Trading Est. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Arno Trading Est. is a pharmaceutical importer based in Amman, Jordan, specializing in the procurement of finished pharmaceutical formulations. The company operates as a buyer, sourcing medications primarily from India, and plays a significant role in the distribution of oncology treatments within the Jordanian market. While specific details about its parent company are not publicly available, Arno Trading Est. is recognized for its focus on high-quality pharmaceutical products, particularly in the oncology therapeutic category.

2Distribution Network

Arno Trading Est. maintains a centralized distribution hub in Amman, strategically located to facilitate efficient logistics and supply chain operations across Jordan. The company's logistics capabilities are tailored to handle the importation and distribution of pharmaceutical products, ensuring timely delivery to various healthcare facilities and pharmacies nationwide. While the primary focus is on the domestic market, there is no publicly available information indicating significant distribution activities beyond Jordan.

3Industry Role

Supplier Relationship Intelligence — Arno Trading Est.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Arno Trading Est. demonstrates a high degree of supplier concentration, sourcing its pharmaceutical products exclusively from two Indian manufacturers: Neon Laboratories Limited and Panacea Biotec Pharma Limited. This sourcing strategy results in a portfolio concentration where the top two products—Dacarbazine and Mitoxantrone—account for 100% of the company's imports. While this approach may streamline procurement processes and foster strong supplier relationships, it also exposes the company to risks associated with over-reliance on a limited number of suppliers. Any disruptions in the supply chain from these manufacturers could significantly impact Arno Trading Est.'s ability to meet market demand.

2Supply Chain Resilience

The resilience of Arno Trading Est.'s supply chain is closely tied to the stability and reliability of its Indian suppliers. The company's exclusive sourcing from Neon Laboratories Limited and Panacea Biotec Pharma Limited suggests a deep integration and reliance on these suppliers. However, the lack of publicly available information regarding backup suppliers or alternative sourcing strategies indicates potential vulnerabilities. Additionally, the company's focus on a narrow range of formulations within the oncology category may limit its ability to adapt to changes in market demand or supply chain disruptions.

3Strategic Implications

Arno Trading Est.'s concentrated sourcing strategy positions it as a specialized distributor of oncology medications in Jordan, potentially allowing for competitive advantages such as favorable pricing and strong supplier relationships. However, the company's heavy reliance on a limited number of suppliers and product categories may pose challenges in terms of supply chain resilience and market adaptability. For Indian exporters, this presents an opportunity to diversify their customer base by offering a broader range of products or alternative formulations that could appeal to Arno Trading Est., thereby reducing the importer's dependency on a narrow product line.

TransData Nexus Research · Verified DGFT customs dataMar 2026

Importing Pharmaceuticals into Jordan — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Jordan

1Regulatory Authority & Framework

The Jordan Food and Drug Administration (JFDA) is the primary regulatory body overseeing the pharmaceutical sector in Jordan. The JFDA is responsible for ensuring the safety, efficacy, and quality of pharmaceutical products through stringent regulations and oversight. Key legislation governing pharmaceutical imports includes the Pharmaceutical Establishments Licensing Regulation No. 162 of 2019, which outlines the requirements for establishing and operating pharmaceutical establishments in Jordan. This regulation mandates that all pharmaceutical products, including those imported, must be registered with the JFDA before they can be marketed or distributed within the country.

2Import Licensing & GMP

Importers of pharmaceutical products in Jordan are required to obtain an importer's card from the Ministry of Industry, Trade, and Supply. This card is essential for customs clearance and is typically issued to registered traders or commercial entities. Additionally, pharmaceutical establishments must adhere to Good Manufacturing Practice (GMP) standards recognized by the JFDA. While the JFDA may consider GMP certifications from reputable international bodies, such as the European Medicines Agency (EMA) or the World Health Organization (WHO), the specific recognition of these certifications is subject to the JFDA's evaluation and approval processes.

3Quality & Labeling

Imported pharmaceutical products must undergo batch testing to ensure they meet the quality standards set by the JFDA. Stability studies are also required to confirm the product's shelf life and efficacy over time. Labeling requirements include the use of Arabic language for all product information, ensuring that consumers and healthcare professionals can access essential details. Serialization mandates are in place to enhance traceability and prevent counterfeit products from entering the market. These measures are part of the JFDA's comprehensive approach to maintaining the integrity and safety of pharmaceutical products in Jordan.

4Recent Regulatory Changes

Between 2024 and 2026, the JFDA implemented stricter controls on the promotion and importation of pharmaceutical drugs. In August 2024, the JFDA announced tighter regulations on the promotion of specific medicines, particularly those with higher risks, such as controlled substances and hospital-only medications. This move aimed to ensure patient safety and prevent misuse. Additionally, in July 2025, the JFDA tightened regulations around bringing pharmaceutical drugs into the Kingdom, allowing patients to import a sufficient quantity of medications for personal use only after obtaining necessary approvals. These measures were designed to limit the entry of unregistered and potentially unsafe medications into the Jordanian market. (petra.gov.jo)

TransData Nexus Research · Jordan regulatory databasesMar 2026

Seller's Guide — How to Become a Supplier to Arno Trading Est.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter Arno Trading Est.'s supply chain by offering alternative formulations or additional oncology medications that complement the existing product line. By diversifying the range of products available, suppliers can help Arno Trading Est. meet a broader spectrum of market demands and reduce its dependency on a limited number of products. Additionally, suppliers that can provide innovative formulations or improved delivery methods may find a receptive partner in Arno Trading Est., which is committed to enhancing the quality and effectiveness of cancer treatments available in Jordan.

2Requirements & Qualifications

Indian exporters seeking to supply Arno Trading Est. must ensure that their products are registered with the JFDA and comply with the regulatory standards set forth by the agency. This includes obtaining necessary approvals, adhering to GMP standards recognized by the JFDA, and ensuring that all labeling and packaging meet the requirements for the Jordanian market. Additionally, exporters should be prepared to provide documentation such as certificates of origin, stability data, and any other information required by the JFDA to facilitate the importation process.

3How to Approach

To establish a relationship with Arno Trading Est., Indian exporters should initiate contact by providing detailed product information, including specifications, regulatory approvals, and compliance with JFDA standards. Participating in industry trade fairs and pharmaceutical conferences in Jordan can also provide opportunities to meet with Arno Trading Est. representatives and discuss potential collaborations. It is advisable to engage in discussions regarding regulatory filing strategies and timelines to ensure a smooth entry into the Jordanian market. Building a strong partnership will require a commitment to quality, reliability, and adherence to the regulatory framework governing pharmaceutical imports in Jordan.

TransData Nexus Research · Industry procurement practicesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Buyer Matching: Arno Trading Est. identified across shipments using consignee name normalization, aggregating 2 name variants.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
3.Market Share: Calculated per product as Arno Trading Est.'s capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 6 individual customs records matching Arno Trading Est..
5.Supplier Verification: Arno Trading Est. sources from 2 verified Indian suppliers across 9 formulations, confirmed from customs records.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2 Products Tracked

1 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

Arno Trading Est.

Arno Trading Est. — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Arno Trading Est.?

What Formulations Does Arno Trading Est. Import?

What Products Does Arno Trading Est. Import?

Top Products by Import Value

Arno Trading Est. Therapeutic Categories — 1 Specializations

Import Portfolio — Top 2 by Import Value

Key Metrics

Top Categories

Indian Suppliers

Arno Trading Est. — Corporate Profile & Information

1Company Overview

2Distribution Network

3Industry Role

Related Trade Data

Need Detailed Data?

Supplier Relationship Intelligence — Arno Trading Est.

1Sourcing Concentration Analysis

2Supply Chain Resilience

3Strategic Implications

Importing Pharmaceuticals into Jordan — Regulatory Framework

1Regulatory Authority & Framework

2Import Licensing & GMP

3Quality & Labeling

4Recent Regulatory Changes

Arno Trading Est. — Procurement Pattern Analysis

1Product Strategy

2Sourcing Profile

3Market Positioning

Seller's Guide — How to Become a Supplier to Arno Trading Est.

1Opportunity Assessment

2Requirements & Qualifications

3How to Approach

Frequently Asked Questions — Arno Trading Est.

What products does Arno Trading Est. import from India?

Who supplies pharmaceuticals to Arno Trading Est. from India?

What is Arno Trading Est.'s total pharmaceutical import value?

What therapeutic categories does Arno Trading Est. focus on?

Get Full Arno Trading Est. Import Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology